Minitran and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Minitran (nitroglycerin) and Ranitidine (ranitidine). Common drug interactions include hyponatraemia among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Minitran and Ranitidine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 950 Minitran users. Check the latest studies of Minitran.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

On Jul, 08, 2026

12 people who take Minitran and Ranitidine together, and have interactions are studied.

Minitran and Ranitidine drug interactions.

What are the common drug interactions of Minitran and Ranitidine, by gender? *:

female:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Renal failure (kidney dysfunction)
Malaise (a feeling of general discomfort or uneasiness)
Oropharyngeal pain
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Chronic kidney disease

male:

Cardiac failure congestive
Cardiovascular disorder (heart diseases)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Intracardiac thrombus (presence of a circumscribed mass with heart wall)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Blood creatine phosphokinase increased
Diarrhoea
Vertigo

What are the common drug interactions of Minitran and Ranitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood creatine phosphokinase increased
Vertigo

60+:

Chronic kidney disease
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Renal failure (kidney dysfunction)
Malaise (a feeling of general discomfort or uneasiness)
Oropharyngeal pain
Diarrhoea
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

Herpes Zoster: 3 people, 25.00%
Ill-Defined Disorder: 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Diabetes: 2 people, 16.67%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 8.33%
Thyroid Diseases: 1 person, 8.33%
Pain: 1 person, 8.33%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Dyslipidaemia (abnormal amount of lipids): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Minitran and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously